Skip to main content
Journal cover image

Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?

Publication ,  Journal Article
Greenberg, A
Published in: Am J Kidney Dis
December 2007

Duke Scholars

Published In

Am J Kidney Dis

DOI

EISSN

1523-6838

Publication Date

December 2007

Volume

50

Issue

6

Start / End Page

904 / 907

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Treatment Outcome
  • Tolvaptan
  • Receptors, Vasopressin
  • Randomized Controlled Trials as Topic
  • Humans
  • Heart Failure
  • Benzazepines
  • Antidiuretic Hormone Receptor Antagonists
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Greenberg, A. (2007). Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure? Am J Kidney Dis, 50(6), 904–907. https://doi.org/10.1053/j.ajkd.2007.10.006
Greenberg, Arthur. “Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?Am J Kidney Dis 50, no. 6 (December 2007): 904–7. https://doi.org/10.1053/j.ajkd.2007.10.006.
Greenberg A. Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure? Am J Kidney Dis. 2007 Dec;50(6):904–7.
Greenberg, Arthur. “Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?Am J Kidney Dis, vol. 50, no. 6, Dec. 2007, pp. 904–07. Pubmed, doi:10.1053/j.ajkd.2007.10.006.
Greenberg A. Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure? Am J Kidney Dis. 2007 Dec;50(6):904–907.
Journal cover image

Published In

Am J Kidney Dis

DOI

EISSN

1523-6838

Publication Date

December 2007

Volume

50

Issue

6

Start / End Page

904 / 907

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Treatment Outcome
  • Tolvaptan
  • Receptors, Vasopressin
  • Randomized Controlled Trials as Topic
  • Humans
  • Heart Failure
  • Benzazepines
  • Antidiuretic Hormone Receptor Antagonists
  • 3202 Clinical sciences